By Miguel Solivan, Marketing Manager, Avery Dennison Medical Medical wearable devices, such as continuous glucose monitors ...

The global vital signs monitoring devices market, valued at USD 25.62 billion in 2022, is projected to grow at a CAGR of 12.7 ...

Introduction Medical wearables have transformed remote patient monitoring. From fitness wearables to advanced health-monitoring devices, wearables are now an in ...

A study that looks into the potential of wearables to non-invasively measure blood glucose has come up with promising results ...

The Wearable Medical Devices Market is expected to witness a healthy double-digit growth rate by 2028. The key factors driving the market are rising incidence of chronic diseases; growing recognition ...

CGMs are transforming health tracking for non-diabetics, providing insights into glucose levels and influencing dietary choices and athletic performance.

Diabetes management has relied on finger-prick blood glucose testing and continuous glucose monitors (CGMs) for decades.

Early disease detection through wearable devices can significantly impact conditions like diabetes and atrial fibrillation (AFib). Continuous glucose monitors (CGMs) offer real-time glucose ...

Diabetics up to the age 25 and those 65 and older will now have their advance glucose monitors paid for by the provincial ...

Programmable electrodes integrated into wearable devices enable selective molecular detection in complex formulations such as ...

Glucotrack, Inc. (NASDAQ: GCTK) is focused on the design, development, and commercialization of novel technologies for people with diabetes. The Company is currently developing a long-term implantable ...